BRVE Smart Money
Braveheart Bio, Inc.
1W: +13.8%
1M: +6.1%
YTD: +21.5%
$21.82
-0.05 (-0.23%)
Weekly Expected Move ±10.2%
$17
$19
$21
$24
$26
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Viehbacher Christopher | director | P-Purchase | 83,333 | $18.00 | $1.5M | Filing |
| 2026-08-07 | Forbion Growth III Management B.V. | 10% owner | P-Purchase | 1,680,000 | $18.00 | $30.2M | Filing |
| 2026-08-07 | Anderson Michele A. | officer: chief development officer | P-Purchase | 1,111 | $18.00 | $20K | Filing |
| 2026-08-07 | Murdoch Travis | officer: ceo and president | P-Purchase | 83,333 | $18.00 | $1.5M | Filing |
| 2026-08-07 | Lubner David Charles | director | P-Purchase | 55,555 | $18.00 | $1000K | Filing |
| 2026-08-07 | Rickey James Paul | officer: chief financial officer | P-Purchase | 27,777 | $18.00 | $500K | Filing |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% owner | C-Conversion | 9,132,420 | $— | $0 | Filing |
| 2026-08-07 | Malek David I | director | P-Purchase | 4,166 | $18.00 | $75K | Filing |
| 2026-08-07 | Forbion Ventures Fund VII Cooperatief U.A. | 10% owner | C-Conversion | 9,132,420 | $— | $0 | Filing |
| 2026-08-07 | Forbion Ventures VII Management B.V. | 10% owner | C-Conversion | 9,132,420 | $— | $0 | Filing |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% owner | C-Conversion | 7,990,867 | $— | $0 | Filing |
| 2026-08-07 | Forbion Growth III Management B.V. | 10% owner | C-Conversion | 7,990,867 | $— | $0 | Filing |
| 2026-08-07 | Forbion Ventures Fund VII Cooperatief U.A. | 10% owner | C-Conversion | 7,990,867 | $— | $0 | Filing |
| 2026-08-07 | Forbion Ventures VII Management B.V. | 10% owner | C-Conversion | 7,990,867 | $— | $0 | Filing |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% owner | P-Purchase | 1,920,000 | $18.00 | $34.6M | Filing |
| 2026-08-07 | Forbion Growth III Management B.V. | 10% owner | P-Purchase | 1,920,000 | $18.00 | $34.6M | Filing |
| 2026-08-07 | Forbion Ventures Fund VII Cooperatief U.A. | 10% owner | P-Purchase | 1,920,000 | $18.00 | $34.6M | Filing |
| 2026-08-07 | Forbion Ventures VII Management B.V. | 10% owner | P-Purchase | 1,920,000 | $18.00 | $34.6M | Filing |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% owner | P-Purchase | 1,680,000 | $18.00 | $30.2M | Filing |
| 2026-08-07 | Chimovits Erez | director | P-Purchase | 1,666,667 | $18.00 | $30.0M | Filing |
| 2026-08-07 | Forbion Ventures Fund VII Cooperatief U.A. | 10% owner | P-Purchase | 1,680,000 | $18.00 | $30.2M | Filing |
| 2026-08-07 | Forbion Ventures VII Management B.V. | 10% owner | P-Purchase | 1,680,000 | $18.00 | $30.2M | Filing |
| 2026-08-07 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% owner | C-Conversion | 7,420,091 | $— | $0 | Filing |
| 2026-08-07 | Chimovits Erez | director | C-Conversion | 9,132,420 | $— | $0 | Filing |
| 2026-08-07 | Forbion Growth III Management B.V. | 10% owner | C-Conversion | 9,132,420 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
0 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| No institutional holdings found | |||||